-
COST-CONSEQUENCE MODEL OF WHOLE-EXOME, WHOLE-TRANSCRIPTOME SEQUENCING VERSUS 50-GENE PANELS FOR GENOMIC PROFILING IN ADVANCED SOLID TUMORS
Feb 25, 2026, 14:42 PM -
IMPACT OF MEDICATION CLUSTERS ON POST-DISCHARGE ADVERSE DRUG EVENTS AND HEALTHCARE UTILIZATION AMONG OLDER ADULTS
Feb 25, 2026, 14:42 PM -
CAR-TUTILIZATION BEFORE AND AFTER THE APPROVAL AS A SECOND-LINE THERAPY FOR DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERRUPTED TIME SERIES ANALYSIS
Feb 25, 2026, 14:42 PM -
PREDICTING PROSTATE CANCER INCIDENCE USING A LARGE, NATIONAL U.S. ELECTRONIC HEALTH RECORDS (EHR) DATABASE
Feb 25, 2026, 14:42 PM -
POLYGENIC RISK SCORES IMPROVE NON-SMALL CELL LUNG CANCER PREDICTION IN REAL-WORLD US DATA
Feb 25, 2026, 14:42 PM -
COST-UTILITY OF FIRST-LINE DOSTARLIMAB PLUS CARBOPLATIN-PACLITAXEL COMPARED WITH PLACEBO FOR PATIENTS WITH PA/REC: A PARTITIONED SURVIVAL ANALYSIS
Feb 25, 2026, 14:42 PM -
PERFORMANCE OF TRANSPORTABILITY METHODS UNDER EFFECT MEASURE MODIFIER OMISSION: A PLASMODE SIMULATION STUDY IN LUNG CANCER SCREENING
Feb 25, 2026, 14:42 PM -
COMPARISON OF SAMPLING STRATEGIES TO ADDRESS SEVERE DATA IMBALANCE AND COMPUTATIONAL BENCHMARKING FOR TIME-TO-EVENT PREDICTIVE MODEL DEVELOPMENT ACROSS LOCAL AND HIGH-PERFORMANCE COMPUTING ENVIRONMENTS: PREDICTION OF ALCOHOL USE DISORDER AND OPIOID...
Feb 25, 2026, 14:42 PM -
ESTIMATING THE HEALTH OPPORTUNITY COST OF PUBLIC HEALTH EXPENDITURE IN KAZAKHSTAN: EMPIRICAL SUPPLY-SIDE COST-EFFECTIVENESS THRESHOLDS
Feb 25, 2026, 14:42 PM -
USE OF REAL-TIME AI-ASSISTED LIVING SYSTEMATIC LITERATURE REVIEW (REAL-SLR) IN PROSTATE CANCER (PC) ENABLES ON-DEMAND ACCESS TO PIVOTAL CLINICAL TRIAL EVIDENCE
Feb 25, 2026, 14:42 PM -
THE BUDGET IMPACT OF INTRODUCING ZONGERTINIB INTO THE FORMULARY FOR TREATMENT-NAÏVE AND PRETREATED HER2-MUTANT ADVANCED NSCLC IN THE UNITED STATES
Feb 25, 2026, 14:42 PM -
ETHICAL AI DEPLOYMENT IN HEOR
Feb 25, 2026, 14:42 PM -
EFFECT OF CHINESE HERBAL MEDICINE COMBINED WITH CONVENTIONAL ANTI-OSTEOPOROTIC MEDICATION ON FRACTURE RISK IN OLDER ADULTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY
Feb 25, 2026, 14:42 PM -
COMPARATIVE EFFECTIVENESS OF SGLT2I, GLP-1, AND METFORMIN ON CARDIOVASCULAR OUTCOMES IN ADULTS WITH SEVERE MENTAL ILLNESS
Feb 25, 2026, 14:42 PM -
DELAYS AND DENIALS FOR BRANDED MEDICATION FILLS DUE TO PRIOR AUTHORIZATION
Feb 25, 2026, 14:42 PM -
TREATMENT AND RECURRENCE PATTERNS AMONG BACILLUS CALMETTE-GUÉRIN EXPERIENCED PATIENTS WITH RECURRENT, PAPILLARY-ONLY HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER
Feb 25, 2026, 14:42 PM -
ECONOMIC IMPACT OF ADDING TALAZOPARIB TO ENZALUTAMIDE IN PATIENTS WITH HRRM MCRPC
Feb 25, 2026, 14:42 PM -
ADVANCING COMPUTABLE OPERATIONAL DEFINITIONS WITH ONTOLOGY MAPPING AND SYNTHETIC DATA SIMULATION FOR MORE CONSISTENT REAL-WORLD EVIDENCE
Feb 25, 2026, 14:42 PM -
ASSESSING SELF-REPORTED HEALTH AND QUALITY OF LIFE IN ETHNICALLY DIVERSE CAREGIVERS FOR PEOPLE WITH AGITATION IN ALZHEIMER'S DEMENTIA
Feb 25, 2026, 14:42 PM -
PERIOD PREVALENCE OF MAJOR COMORBIDITIES FOLLOWING THE DIAGNOSIS OF GRAVES’ DISEASE: A NATIONWIDE COHORT STUDY IN SOUTH KOREA
Feb 25, 2026, 14:42 PM
